A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

NCT04544787 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Pierre Van Damme

Collaborators